KBR:NYSEKBR, Inc. Analysis
Data as of 2026-05-21 - not real-time
$31.59
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
KBR trades at $31.59, sitting below its 20‑day SMA of $33.88 and 50‑day SMA of $35.73, with the 200‑day SMA still at $42.23, signaling a clear bearish price trend. The RSI of 38 and a bearish MACD histogram reinforce the downside momentum, while the stock hovers just above the identified support level of $29.94 and faces resistance near $39.07. Volatility is elevated at over 43% (30‑day) and a beta of 0.77 points to heightened sensitivity to market swings.
Fundamentally, KBR appears cheap relative to peers – its trailing PE of 9.3 is far below the industry average of 29.3 and its price‑to‑sales ratio is only 0.52. The company yields 2.04% dividend with a modest 19% payout, supported by solid ROE of 29% and free cash flow of $250 M. However, revenue contracted 5% YoY, gross margins sit at just 14.5%, and a debt‑to‑equity ratio of 177% reflects a heavy leverage burden, with net debt far exceeding cash on hand. A discounted cash‑flow model places fair value near $6.26, implying substantial downside from current pricing, though a recent $449 M Army contract award and a newly declared quarterly dividend provide short‑term upside catalysts.
Fundamentally, KBR appears cheap relative to peers – its trailing PE of 9.3 is far below the industry average of 29.3 and its price‑to‑sales ratio is only 0.52. The company yields 2.04% dividend with a modest 19% payout, supported by solid ROE of 29% and free cash flow of $250 M. However, revenue contracted 5% YoY, gross margins sit at just 14.5%, and a debt‑to‑equity ratio of 177% reflects a heavy leverage burden, with net debt far exceeding cash on hand. A discounted cash‑flow model places fair value near $6.26, implying substantial downside from current pricing, though a recent $449 M Army contract award and a newly declared quarterly dividend provide short‑term upside catalysts.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below key moving averages and bearish MACD
- High short‑term volatility and proximity to support
- Dividend yield provides limited cushion
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Attractive valuation multiples versus industry peers
- Stable dividend and solid ROE
- Potential upside from government contract pipeline
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount (PE, price‑to‑sales)
- Consistent dividend and strong cash generation
- Long‑run secular demand for engineering and decarbonization services
Key Metrics & Analysis
Financial Health
Revenue Growth-4.70%
Profit Margin5.21%
P/E Ratio9.3
ROE29.15%
ROA4.98%
Debt/Equity176.90
P/B Ratio2.7
Op. Cash Flow$534.0M
Free Cash Flow$250.4M
Industry P/E29.3
Technical Analysis
TrendBearish
RSI38.1
Support$29.94
Resistance$39.07
MA 20$33.88
MA 50$35.73
MA 200$42.23
MACDBearish
VolumeStable
Fear & Greed Index89.68
Valuation
Fair Value$6.26
Target Price$48.63
Upside/Downside53.93%
GradeUndervalued
TypeValue
Dividend Yield2.04%
Risk Assessment
Beta0.77
Volatility43.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.